跳至主要内容
临床试验/ITMCTR2100005396
ITMCTR2100005396已完成未知

Analysis of Overall Survival Rate and Cost-effectiveness of Different Integrated Traditional Chinese and Western Medicine Schemes in the Treatment of Primary Liver Cancer

Hongying Zhang0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

年龄范围
32 至 86(—)
性别
All

入选标准

  • (1) Age = 18 years; (2) No treatment before diagnosis; (3) Complete regular follow-up or examination; (4) Patients with Beijing medical insurance.

排除标准

  • (1) Patients with metastatic liver cancer; (2) Pregnant or lactating women; (3) Patients with an estimated survival time of less than three months; (4) Patients with incomplete clinical information.

研究者

发起方
Hongying Zhang

相似试验